SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
---------------------
FORM 8-K/A
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Earliest Event Reported
June 7, 2002
Bepariko BioCom
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
NEVADA
- --------------------------------------------------------------------------------
(State or other jurisdiction of incorporation of organization)
000-27339 88-0426887
- -------------------------------------- ------------------------------------
(Commission File Number) (IRS Employer Identification Number)
GSB Building, Suite 417
Bala Cynwyd, Pennsylvania 19004
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (610) 660-5906
Item 4. Changes in Registrants Certifying Accountant
As previously reported in a Current Report on Form 8-K filed by the
Company on May 13, 2002, on May 3, 2002, the Company's board of directors
approved the dismissal of Kurt D. Saliger, C.P.A., the principal accountants
previously engaged to audit the Company's financial statements.
Attached as Exhibit 16.1 to this Current Report on Form 8-K/A is a copy
of the letter which Kurt D. Saliger, C.P.A. was required to send to the
Securities and Exchange Commission pursuant to Item 304(a)(3) of Regulation S-B.
The Company received a copy of this letter on June 7, 2002.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(a) Not applicable.
(b) Not applicable.
(c) Exhibits.
16.1 Letter from Kurt D. Saliger, C.P.A. dated June 6, 2002
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BEPARIKO BIOCOM
Registrant
By: /s/ Cecile Coady
------------------------
Cecile Coady, President
Date: June 10, 2002